Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia
Abstract Notch signaling is considered a rational target in the therapy of several cancers, particularly those harbouring Notch gain of function mutations, including T-cell acute lymphoblastic leukemia (T-ALL). Although currently available Notch-blocking agents are showing anti-tumor activity in pre...
Main Authors: | Mattia Mori, Luca Tottone, Deborah Quaglio, Nadezda Zhdanovskaya, Cinzia Ingallina, Marisa Fusto, Francesca Ghirga, Giovanna Peruzzi, Maria Elisa Crestoni, Fabrizio Simeoni, Francesca Giulimondi, Claudio Talora, Bruno Botta, Isabella Screpanti, Rocco Palermo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-02316-9 |
Similar Items
-
Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL
by: Luca Tottone, et al.
Published: (2019-04-01) -
NF-κB1 Regulates Immune Environment and Outcome of Notch-Dependent T-Cell Acute Lymphoblastic Leukemia
by: Paola Grazioli, et al.
Published: (2020-04-01) -
Notch3/Jagged1 Circuitry Reinforces Notch Signaling and Sustains T-ALL
by: Maria Pelullo, et al.
Published: (2014-12-01) -
Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells
by: Simona Ceccarelli, et al.
Published: (2019-01-01) -
The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.
by: Sung Hee Choi, et al.
Published: (2017-01-01)